Bovine IgG1 sheep polyclonal antibody, AP
Applications | ELISA: 1/1000-1/10000. |
Reactivities | Bovine |
Conjugation | AP |
Immunogen | Purified Bovine IgG1. |
Bovine IgG1 sheep polyclonal antibody, AP
Applications | ELISA: 1/1000-1/10000. |
Reactivities | Bovine |
Conjugation | AP |
Immunogen | Purified Bovine IgG1. |
USD 705.00
2 Weeks
Human IgA (Secretory component, free and bound) sheep polyclonal antibody, HRP
Applications | This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. |
Reactivities | Human |
Conjugation | HRP |
Immunogen | Purified free human secretory component isolated from pooled milk is used for immunization. Freund’s complete adjuvant is used in the first step of the immunization procedure. |
Human IgA (Fc specific) sheep polyclonal antibody, TRITC
Applications | Direct staining of fixed cell and tissue substrates, to demonstrate the intracellular presence of IgA. The absence of the Fc domain in the conjugate ensures minimal interaction with the tissue components and cell surfaces other than the primary antibody activity. This conjugate is primarily intended for use in cell surface membrane staining procedures, to identify and quantitate Ig on B cells, especially if interference by Fc activity is expected. Recommended Dilutions: 1/10-1/40 This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. |
Reactivities | Human |
Conjugation | TRITC |
Immunogen | Purified IgA prepared from pooled Human serum. Freund’s complete adjuvant is used in the first step of the immunization procedure. |
Human IgG (Fc specific) sheep polyclonal antibody, TRITC
Applications | Direct staining of fixed cell and tissue substrates, to demonstrate the intracellular presence of IgG. The absence of the Fc domain in the conjugate ensures minimal interaction with the tissue components and cell surfaces other than the primary antibody activity. This conjugate is primarily intended for use in cell surface membrane staining procedures, to identify and quantitate Ig on B cells, especially if interference by Fc activity is expected. Recommended Dilutions: 1/10-1/40 This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. |
Reactivities | Human |
Conjugation | TRITC |
Immunogen | Purified IgG prepared from pooled Human serum. Freund’s complete adjuvant is used in the first step of the immunization procedure. |
Bovine IgG2 sheep polyclonal antibody, AP
Applications | ELISA: 1/1000-1/10000. |
Reactivities | Bovine |
Conjugation | AP |
Immunogen | Purified Bovine IgG2. |
Bovine IgG sheep polyclonal antibody, AP
Applications | ELISA: 1/5000-1/50000. |
Reactivities | Bovine |
Conjugation | AP |
Immunogen | Purified Bovine IgG. |
Bovine IgG sheep polyclonal antibody, FITC
Applications | Flow Cytometry. Immunohistochemistry on Frozen Sections: 1/200-1/2,000. |
Reactivities | Bovine |
Conjugation | FITC |
Immunogen | Purified Bovine IgG. |
Bovine IgG sheep polyclonal antibody, HRP
Applications | ELISA: 1/10,000-1/100,000. Western Blot. |
Reactivities | Bovine |
Conjugation | HRP |
Immunogen | Purified Bovine IgG. |
Bovine IgG sheep polyclonal antibody, Purified
Applications | ELISA: 1/100-1/10,000. Immunodiffusion. |
Reactivities | Bovine |
Conjugation | Unconjugated |
Immunogen | Purified Bovine IgG. |
Bovine IgM sheep polyclonal antibody, AP
Applications | ELISA: 1/1000-1/10000. Western Blot: 1/5000-1/50000. |
Reactivities | Bovine |
Conjugation | AP |
Immunogen | Purified Bovine IgM. |